テキサスにおける肝疾患の臨床試験
テキサス内の拠点で、肝疾患に関する14件の研究が参加者を募集しています。
テキサス内の都市
- Houston10件の研究
- San Antonio6件の研究
- Dallas5件の研究
- Austin4件の研究
- Round Rock3件の研究
- Brownsville3件の研究
- Carrollton3件の研究
- Fort Worth3件の研究
公式研究テキスト（英語）
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Texas Liver Institute, San Antonio
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/24更新 · NCT07654283A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Pinnacle Clinical Research, Austin
- Bellaire Clinical Research, Bellaire
- South Texas Research Institute (STRI) - Brownsville, Brownsville
- 他14件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/09更新 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 他30件
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 他21件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/03更新 · NCT06419374Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
- MD Anderson Cancer Center, Houston
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/06更新 · NCT07010315Primary Sclerosing Cholangitis in Children
- Texas Children's Hospital (Baylor College of Medicine), Houston
被験者募集中観察研究
2歳〜25歳 · 全性別 · 2026/07/14更新 · NCT04181138Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
被験者募集中
18歳〜80歳 · 全性別 · 2026/06/25更新 · NCT06068491A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- Clinical Trial Site, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/17更新 · NCT06600321A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Texas Liver Institute - American Research Corporation, San Antonio
- Pinnacle Clinical Research, San Antonio
被験者募集中第1相
18歳〜80歳 · 全性別 · 2026/06/16更新 · NCT07559474A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- St. David's South Austin Medical Center, Austin
- UT Southwestern Medical Center, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2025/10/20更新 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2025/09/23更新 · NCT05028829Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
- Houston Methodist Hospital, Houston
被験者募集中第2相
18歳〜70歳 · 全性別 · 2025/08/08更新 · NCT04496479Hepatic Histopathology in Urea Cycle Disorders
- Baylor College of Medicine, Houston
被験者募集中観察研究
全年齢 · 全性別 · 2025/07/20更新 · NCT04908319ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。